Cargando…

Arginine deprivation therapy for malignant melanoma

Despite recent development of promising immunotherapeutic and targeted drugs, prognosis in patients with advanced melanoma remains poor, and a cure for this disease remains elusive in most patients. The success of melanoma therapy depends on a better understanding of the biology of melanoma and deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Jung-Ki, Frankel, Arthur E, Feun, Lynn G, Ekmekcioglu, Suhendan, Kim, Kevin B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534294/ https://www.ncbi.nlm.nih.gov/pubmed/23293541 http://dx.doi.org/10.2147/CPAA.S37350

Ejemplares similares

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
por: Li, Ying-Ying, et al.
Publicado: (2016)

Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma
por: Wu, Chunjing, et al.
Publicado: (2021)

Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy
por: Kim, Sun-Hee, et al.
Publicado: (2018)

Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation
por: Li, Ying‐Ying, et al.
Publicado: (2017)

Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
por: Savaraj, Niramol, et al.
Publicado: (2015)

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
por: Feun, L G, et al.
Publicado: (2012)

Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
por: Kuo, Macus Tien, et al.
Publicado: (2010)

Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy
por: Kuo, Macus Tien, et al.
Publicado: (2021)

Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
por: Carpentier, Joséphine, et al.
Publicado: (2022)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

A Case of Intracranial Hemorrhage Caused by Combined Dabrafenib and Trametinib Therapy for Metastatic Melanoma
por: Lee, Le Min, et al.
Publicado: (2014)

Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells
por: Ahmed, Rebaz, et al.
Publicado: (2021)

The TWEAK Receptor Fn14 is a Novel Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
por: Zhou, Hong, et al.
Publicado: (2012)

Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ
por: Tanese, Keiji, et al.
Publicado: (2015)

Targeting iNOS to increase efficacy of immunotherapies
por: Ekmekcioglu, Suhendan, et al.
Publicado: (2017)

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003)

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jie Qing, et al.
Publicado: (2013)

Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma
por: Kraehenbuehl, Lukas, et al.
Publicado: (2022)

The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival
por: Ogata, Dai, et al.
Publicado: (2020)

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
por: Sun, Naihui, et al.
Publicado: (2022)

Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells
por: Wheatley, D N, et al.
Publicado: (2003)

HGG-13. Combined CDK inhibition and arginine-deprivation as targeted therapy for arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
por: Ogata, Dai, et al.
Publicado: (2021)

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells
por: Scott, L, et al.
Publicado: (2000)

Optimizing arginine deprivation for hard-to-treat cancers
por: Khadeir, Ramsay, et al.
Publicado: (2017)

Bench-to-Bedside Studies of Arginine Deprivation in Cancer
por: Field, George C., et al.
Publicado: (2023)

Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors
por: Hajji, Nabil, et al.
Publicado: (2022)

Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion
por: Fukuda, Yasunari, et al.
Publicado: (2023)

iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation
por: Ding, Zhen, et al.
Publicado: (2021)

Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers
por: Rogers, Leonard C., et al.
Publicado: (2019)

Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment
por: Chu, Yu-De, et al.
Publicado: (2023)

Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma
por: Fukuda, Yasunari, et al.
Publicado: (2022)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma
por: Fukuda, Yasunari, et al.
Publicado: (2022)

PET/CT Findings of a Patient with Cardiac Metastasis of Subungual Malign Melanoma
por: Ekmekçioğlu, Özgül, et al.
Publicado: (2019)

Characterization of the Inflammatory Microenvironment and Identification of Potential Therapeutic Targets in Wilms Tumors()()
por: Maturu, Paramahamsa, et al.
Publicado: (2014)

Deprivation of arginine by recombinant human arginase in prostate cancer cells
por: Hsueh, Eddy C, et al.
Publicado: (2012)

Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes
por: Alexandrou, Constantinos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0p10orfk9kigk6k13l15qfl3lq